Papers in Atherosclerosis Plus
Page 1 · newest first
- PCSK9 inhibitors and atherosclerotic plaque regression and stabilisation across major arterial beds: a systematic review with narrative synthesisAtherosclerosis Plus · 2026
- Simulation of low-density lipoprotein cholesterol goal attainment with treatment intensification in a population with homozygous familial hypercholesterolemiaAtherosclerosis Plus · 2026
- Aortic Plaque Morphology and Cholesterol Crystal Release Assessed Using Non-Obstructive General AngioscopyAtherosclerosis Plus · 2026
- Long-term real-world efficacy of inclisiran at 15 months: new results from the INCLIVEN multicenter registryAtherosclerosis Plus · 2026
- Sex-related patterns of LDL-C/small dense LDL-C discordance among Japanese adults with non-elevated LDL-CAtherosclerosis Plus · 2026
- Choline fenofibrate add-on to statins in persistent hypertriglyceridemia: efficacy, apoB-containing lipoprotein remodeling, and renal functionAtherosclerosis Plus · 2026
- Arginine and homoarginine as predictors of cardiovascular mortality in chronic coronary syndromeAtherosclerosis Plus · 2026
- Apolipoprotein C-III inhibitors reduce triglycerides and acute pancreatitis risk: a systematic review and meta-analysisAtherosclerosis Plus · 2026
- Global Genetic Architecture of Familial Chylomicronaemia Syndrome: Insights from the FCS International Collaboration Project (FCS IP).Atherosclerosis Plus · 2026
- The value and limitations of genetic testing in diagnosing and advising on cardiovascular risk in the rare Tangier DiseaseAtherosclerosis Plus · 2026
- How calculated LDL-cholesterol compares with direct measurement: performance and cost analysis from a large NHS service evaluationAtherosclerosis Plus · 2026
- TUDOR: a treatment-adjusted diagnostic algorithm for familial hypercholesterolaemia with dual external validation in 4,028 genetically confirmed casesAtherosclerosis Plus · 2026
- Lipoprotein (a) testing- insights from the laboratoryAtherosclerosis Plus · 2026
- Clonal Hematopoiesis is Associated with Adverse Events in Patients with High-Grade Carotid Artery StenosisAtherosclerosis Plus · 2026
- Lipoprotein(a) and early LDL-cholesterol target attainment after a first acute coronary syndrome: a real-world cohort studyAtherosclerosis Plus · 2026
- Very low HDL cholesterol in infectious mononucleosis with hepatitis: a real-world evidence studyAtherosclerosis Plus · 2026
- Plasma untargeted metabolomics in coronary artery disease – Correlation with degree of obstructionAtherosclerosis Plus · 2026
- Association between serum lipoprotein(a) levels and aortic vulnerable plaques assessed by non-obstructive general angioscopyAtherosclerosis Plus · 2026
- Orthopedic Surgery changes Aortic Valve Composition in ApoE-/- mice.Atherosclerosis Plus · 2026
- Putative protective role of PCSK9 variants in a multigenerational family with familial hypercholesterolemiaAtherosclerosis Plus · 2026
- Association of Lipoprotein(a) with the Angiographic Extent of Coronary Artery Disease and Selected Angiographic Findings in Patients with Acute Coronary Syndromes.Atherosclerosis Plus · 2026
- Associations Between Carotid Macrovascular and Retinal Microvascular Alterations in Diabetes: Evidence Synthesis and Implications for Risk AssessmentAtherosclerosis Plus · 2026
- The association between albuminuria and coronary atherosclerotic burden in the general populationAtherosclerosis Plus · 2026
- Microbial mechanisms in atherosclerosis: Revisiting the infectious hypothesisAtherosclerosis Plus · 2026
- Associations of long-term vitamin K antagonist and direct oral anticoagulant therapies with progression of coronary artery calcification: A Danish population-based studyAtherosclerosis Plus · 2026
- Cholesterol in amyotrophic lateral sclerosis: a bystander, a biomarker, or a target?Atherosclerosis Plus · 2026
- LDL-Cholesterol Distance to Target: A Practical Tool for Guiding Lipid-Lowering Treatment DecisionsAtherosclerosis Plus · 2026
- Real-world Cardiovascular Risk Estimation, Blood Pressure and LDL-Cholesterol Control: Two Epidemiological Studies in Romania, during pandemic and post-pandemic (SNAPSHOT-Romania)Atherosclerosis Plus · 2026
- Effects of evolocumab on plasma coenzyme Q10 in patients with heterozygous familial hypercholesterolemiaAtherosclerosis Plus · 2026
- Awareness and perceptions of systemic inflammation in atherosclerotic cardiovascular disease and chronic kidney disease: The SPARK-CVD China surveyAtherosclerosis Plus · 2026
- Retinal findings in familial hypercholesterolemia: An exploratory case-control studyAtherosclerosis Plus · 2026
- Lipoprotein metabolism and inflammation in healthy young subjects – exploring the postprandial and postabsorptive phases following intake of a standardized mealAtherosclerosis Plus · 2026
- Association of the C-reactive protein-triglyceride-glucose index (CTI) with lower-extremity peripheral artery disease among U.S. adultsAtherosclerosis Plus · 2026
- Parallel screening strategies reveal distinct phenotypic and genotypic profiles of familial hypercholesterolemia in children and adultsAtherosclerosis Plus · 2026
- Expert Consensus on Lipoprotein(a) in the Gulf Countries: Navigating Cardiovascular Risk and Therapeutic AdvancesAtherosclerosis Plus · 2026
- Sex-Specific Associations of the Triglyceride-Glucose Index With Systemic Inflammation and Arterial Stiffness in Adults With Normal Glucose and Triglyceride LevelsAtherosclerosis Plus · 2026
- Associations of lipoprotein(a) concentrations with cardiovascular disease in men and women with primary hypercholesterolemiaAtherosclerosis Plus · 2026
- Environmental pollution, apolipoprotein A-1 autoantibodies and cardiovascular risk: evidence from a geospatial cross-sectional studyAtherosclerosis Plus · 2026
- CNN3 promotes vascular smooth muscle cells proliferation and migration to deteriorate atherosclerosis by β-catenin signaling pathwayAtherosclerosis Plus · 2026
- Plasma-derived small extracellular vesicle miR-660-5p as a predictor for carotid plaque vulnerability and postoperative major adverse cardiovascular event riskAtherosclerosis Plus · 2026
- Systematic literature review on the real-world effectiveness and safety of bempedoic acidAtherosclerosis Plus · 2026
- Proprotein convertase subtilisin/kexin type 9–CC-motif chemokine ligand 2 interactions link lipoprotein(a) composition to intermediate monocyte inflammation in coronary artery diseaseAtherosclerosis Plus · 2026
- Calciprotein particles disrupt autophagy in vascular endothelial cells and smooth muscle cellsAtherosclerosis Plus · 2026
- Association between HIV Infection and Arterial Stiffness: A Population-Based Cross-Sectional Study from Rakai, South Western Uganda.Atherosclerosis Plus · 2026
- PCSK9 in vascular smooth muscle cells: biology, pathology, and inhibition to fight atherosclerosisAtherosclerosis Plus · 2026
- Associations of NMR Metabolic Biomarkers and Arterial Calcification: an Observational and Mendelian Randomization Study within the BBMRI Metabolomics ConsortiumAtherosclerosis Plus · 2026
- Is there a link between non-steroidal anti-inflammatory drugs and cardiovascular risk in patients with inflammatory arthritis?Atherosclerosis Plus · 2026
- Population-based reference intervals for lipid function tests in pregnant and non-pregnant women in Nairobi City, KenyaAtherosclerosis Plus · 2026
- Role of Abnormal Phosphatidylcholine Metabolism in Endoplasmic Reticulum Stress-Induced Carotid Artery Plaque DestabilizationAtherosclerosis Plus · 2026
- Role and mechanism of G9A-BMP2 in calcification-induced formation of unstable plaqueAtherosclerosis Plus · 2026